Cas no 948570-75-0 (1-(2-methoxyethyl)-4-nitro-pyrazole)

1-(2-methoxyethyl)-4-nitro-pyrazole is a synthetic organic compound characterized by its nitro-substituted pyrazole core. It exhibits notable chemical stability and reactivity, making it a valuable intermediate in the synthesis of various pharmaceuticals and agrochemicals. This compound offers high purity and consistent batch-to-batch quality, facilitating efficient chemical transformations in research and industrial applications.
1-(2-methoxyethyl)-4-nitro-pyrazole structure
948570-75-0 structure
Product Name:1-(2-methoxyethyl)-4-nitro-pyrazole
CAS No:948570-75-0
MF:C6H9N3O3
MW:171.153960943222
MDL:MFCD02755678
CID:829562
PubChem ID:57820554
Update Time:2025-11-01

1-(2-methoxyethyl)-4-nitro-pyrazole Chemical and Physical Properties

Names and Identifiers

    • 1-(2-methoxyethyl)-4-nitro-1H-Pyrazole
    • 1-(2-methoxyethyl)-4-nitropyrazole
    • 1H-Pyrazole, 1-(2-methoxyethyl)-4-nitro-
    • SGZBZPUTFUMZBQ-UHFFFAOYSA-N
    • KM3319
    • AK202787
    • V9483
    • COCCN1C=C(C=N1)[N+]([O-])=O
    • 1-(2-Methoxyethyl)-4-nitro-1H-pyrazole (ACI)
    • 1-(2-methoxyethyl)-4-nitro-pyrazole
    • MFCD02755678
    • DS-10308
    • SY236652
    • DA-31361
    • SCHEMBL2173500
    • CS-0124091
    • 948570-75-0
    • DTXSID601284996
    • YMB57075
    • AKOS027253177
    • MDL: MFCD02755678
    • Inchi: 1S/C6H9N3O3/c1-12-3-2-8-5-6(4-7-8)9(10)11/h4-5H,2-3H2,1H3
    • InChI Key: SGZBZPUTFUMZBQ-UHFFFAOYSA-N
    • SMILES: [O-][N+](C1=CN(CCOC)N=C1)=O

Computed Properties

  • Exact Mass: 171.06439116g/mol
  • Monoisotopic Mass: 171.06439116g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 12
  • Rotatable Bond Count: 3
  • Complexity: 159
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 72.9
  • XLogP3: -0.2

1-(2-methoxyethyl)-4-nitro-pyrazole Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A049002818-5g
1-(2-Methoxyethyl)-4-nitro-1H-pyrazole
948570-75-0 95%
5g
$161.12 2023-08-31
Alichem
A049002818-25g
1-(2-Methoxyethyl)-4-nitro-1H-pyrazole
948570-75-0 95%
25g
$475.28 2023-08-31
Alichem
A049002818-100g
1-(2-Methoxyethyl)-4-nitro-1H-pyrazole
948570-75-0 95%
100g
$813.96 2023-08-31
TRC
B486310-10mg
1-(2-Methoxyethyl)-4-nitro-1H-pyrazole
948570-75-0
10mg
$ 50.00 2022-06-07
TRC
B486310-50mg
1-(2-Methoxyethyl)-4-nitro-1H-pyrazole
948570-75-0
50mg
$ 65.00 2022-06-07
TRC
B486310-100mg
1-(2-Methoxyethyl)-4-nitro-1H-pyrazole
948570-75-0
100mg
$ 80.00 2022-06-07
SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd.
M897351-25g
1-(2-Methoxyethyl)-4-nitro-1H-pyrazole
948570-75-0 97%
25g
2,468.70 2021-05-17
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-PG382-5g
1-(2-methoxyethyl)-4-nitro-pyrazole
948570-75-0 97%
5g
822.0CNY 2021-08-04
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-PG382-50mg
1-(2-methoxyethyl)-4-nitro-pyrazole
948570-75-0 97%
50mg
57.0CNY 2021-08-04
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-PG382-1g
1-(2-methoxyethyl)-4-nitro-pyrazole
948570-75-0 97%
1g
406.0CNY 2021-08-04

1-(2-methoxyethyl)-4-nitro-pyrazole Production Method

Production Method 1

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Acetonitrile ;  18 h, 60 °C
Reference
Preparation of hydroxyamidine derivatives useful as indoleamine 2,3-dioxygenase inhibitors
, World Intellectual Property Organization, , ,

Production Method 2

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Acetonitrile ;  6 h, reflux
Reference
Structure-based design and synthesis of pyrimidine-4,6-diamine derivatives as Janus kinase 3 inhibitors
Yu, Ru-Nan; Chen, Cheng-Juan; Shu, Lei; Yin, Yuan; Wang, Zhi-Jian; et al, Bioorganic & Medicinal Chemistry, 2019, 27(8), 1646-1657

Production Method 3

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Acetonitrile ;  rt; 5 h, rt → 90 °C
Reference
Preparation of substituted pyrimidine compounds as inhibitors of epidermal growth factor receptor (EGFR) kinases for treating cancer
, World Intellectual Property Organization, , ,

Production Method 4

Reaction Conditions
1.1 Reagents: Triphenylphosphine ,  Di-tert-butyl azodicarboxylate Solvents: Tetrahydrofuran ;  0 °C; 4 - 16 h, rt
Reference
Preparation of pyrazole derivatives and compositions containing them for the treatment and prevention of diseases associated with hypermineralization
, World Intellectual Property Organization, , ,

Production Method 5

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Acetonitrile ;  12 h, 80 °C
Reference
Preparation of sulphonyl urea derivatives as NLRP3 inflammasome modulators for the treatment of inflammatory, autoinflammatory, autoimmune and neoplastic diseases
, World Intellectual Property Organization, , ,

Production Method 6

Reaction Conditions
1.1 Solvents: Acetonitrile ;  6 h, rt → 60 °C
Reference
Preparation of substituted pyrrolopyrimidine compounds, compositions thereof, and their use in the treatment of triple negative breast cancer
, United States, , ,

Production Method 7

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Dimethylformamide ;  4 h, 100 °C
Reference
Preparation of heterocyclic compounds as CDK kinase inhibitors for the treatment of cancer
, World Intellectual Property Organization, , ,

Production Method 8

Reaction Conditions
1.1 Reagents: Potassium carbonate Catalysts: Potassium iodide Solvents: Acetonitrile ;  overnight, reflux
Reference
Preparation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as jak kinase inhibitors
, World Intellectual Property Organization, , ,

Production Method 9

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Acetonitrile ;  4 h, 80 °C
Reference
Preparation of pyrazolylaminopyrimidinylbenzylthiazolecarboxamide derivatives and analogs for use as Bruton's tyrosine kinase inhibitors
, World Intellectual Property Organization, , ,

Production Method 10

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Acetonitrile ;  5 h, rt → 90 °C
Reference
Substituted pyrimidine compounds, compositions and medicinal applications thereof
, India, , ,

Production Method 11

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Acetonitrile ;  rt → 80 °C; 16 h, 80 °C
Reference
Pyrimidine derivatives as EGFR inhibitors and their preparation, pharmaceutical compositions and use in the treatment of lung cancer
, World Intellectual Property Organization, , ,

Production Method 12

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Acetonitrile ;  rt → 80 °C; 16 h, 80 °C
Reference
Pyrimidopyrazole compounds as fourth generation EGFR inhibitors
, World Intellectual Property Organization, , ,

Production Method 13

Reaction Conditions
1.1 Reagents: Sodium hydride Solvents: Dimethylformamide ;  rt; 30 min, rt
1.2 rt; 16 h, rt
1.3 Solvents: Water ;  rt
Reference
Preparation of thiazolo[5,4-d]pyrimidine derivatives as IRAK kinase inhibitors and uses thereof
, World Intellectual Property Organization, , ,

Production Method 14

Reaction Conditions
1.1 Reagents: Triphenylphosphine ,  Diethyl azodicarboxylate Solvents: Tetrahydrofuran ;  0 °C; 0 °C → rt; 3 h, rt
Reference
Five-and-six-membered heterocyclic compound, its preparation method and pharmaceutical application
, World Intellectual Property Organization, , ,

Production Method 15

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Dimethylformamide ;  3 d, 60 °C
Reference
Preparation of fused pyrimidine compounds for the treatment of cancers associated with EGFR and HER2 mutations and their compositions containing them
, World Intellectual Property Organization, , ,

Production Method 16

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Dimethylformamide ;  16 h, 50 °C
Reference
Preparation of pyrazole derivatives as JAK inhibitors for treatment of autoimmune disease or cancer
, World Intellectual Property Organization, , ,

Production Method 17

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Acetonitrile ;  18 h, reflux
Reference
Nitrogen-containing heteroaromatic ring derivative as tyrosine kinase inhibitor and its preparation
, World Intellectual Property Organization, , ,

Production Method 18

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Acetonitrile ;  6 h, 60 °C
Reference
Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study
Wang, Ruifeng; Zhao, Xiangxin; Yu, Sijia; Chen, Yixuan; Cui, Hengxian; et al, Bioorganic Chemistry, 2020, 102,

Production Method 19

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Acetonitrile ;  12 h, reflux
Reference
Preparation of substituted phenylpyrimidine derivative as JAK inhibitor for treating autoimmune disease
, China, , ,

1-(2-methoxyethyl)-4-nitro-pyrazole Raw materials

1-(2-methoxyethyl)-4-nitro-pyrazole Preparation Products

Recommended suppliers
Yunnanjiuzhen
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Yunnanjiuzhen
Nanjing Jubai Biopharm
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm
ASIACHEM I&E (JIANGSU) CO., LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
ASIACHEM I&E (JIANGSU) CO., LTD
NewCan Biotech Limited
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
NewCan Biotech Limited
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd